Compare VALN & GAIN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | VALN | GAIN |
|---|---|---|
| Founded | 2012 | 2005 |
| Country | France | United States |
| Employees | N/A | 70 |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Finance: Consumer Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 536.9M | 646.9M |
| IPO Year | 2021 | N/A |
| Metric | VALN | GAIN |
|---|---|---|
| Price | $5.43 | $16.64 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 2 | 2 |
| Target Price | ★ $15.50 | $14.75 |
| AVG Volume (30 Days) | 92.8K | ★ 330.0K |
| Earning Date | 05-07-2026 | 05-12-2026 |
| Dividend Yield | N/A | ★ 9.19% |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $9.07 |
| Revenue Next Year | $93.87 | $7.32 |
| P/E Ratio | ★ N/A | $4.38 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $5.15 | $13.14 |
| 52 Week High | $12.25 | $16.94 |
| Indicator | VALN | GAIN |
|---|---|---|
| Relative Strength Index (RSI) | 29.03 | 75.42 |
| Support Level | $5.15 | $13.55 |
| Resistance Level | $6.42 | N/A |
| Average True Range (ATR) | 0.25 | 0.37 |
| MACD | 0.10 | 0.05 |
| Stochastic Oscillator | 18.11 | 84.02 |
Valneva SE is a vaccine company focused on developing life-saving vaccines. Its portfolio includes three vaccines for travelers. The segments of the group are Commercialized vaccines which relate to marketed vaccines, the group's vaccines IXIARO/JESPECT, DUKORAL, IXCHIQ; Covid includes development, manufacturing, & distribution related to the COVID-19 vaccine, Vaccine candidates which relate to research and development programs to generate new approvable products to generate future cash flows from product sales through partnering with pharmaceutical companies; & Technologies and services which relate to services and inventions at a commercialization stage. The company generates majority of its revenue from product sales.
Gladstone Investment Corp operates as an externally managed, closed-end, non-diversified management investment company. Its objective is to invest in debt and equity securities of established private businesses operating in the U.S. and to achieve and grow current income by investing in debt securities of established businesses; provide the stockholders with long-term capital appreciation in the value of its assets by investing in equity securities of established businesses. It focuses on investing in lower-middle-market private businesses.